Pioglitazone Hydrochloride
- Product NDC
- 68071-2170
- 11-digit product format
- 680712170
- Labeler code
- 68071
- Product ID
- 68071-2170_bc090f91-6be3-0bb9-e053-2a95a90a3982
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- pioglitazone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA200044
- Marketing category
- ANDA
- Marketing start
- 2013-02-13
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-2170 | PIOGLITAZONE HYDROCHLORIDE TABLET [NUCARE PHARMACEUTICALS, INC.] | 4 | Legacy NDC | 20240823_46f1f990-7dc2-027b-e054-00144ff8d46c.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2170-3 | 68071217003 | 30 TABLET in 1 BOTTLE (68071-2170-3) | 30 tablet | 2017-01-25 | 0000-00-00 | No | No | Current |